Regeneration After Radiation- and Immune-Mediated Tissue Injury Is Not Enhanced by Type III Interferon Signaling
- 1 March 2019
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 103 (4) , 970-976
Abstract
No abstract availableKeywords
Funding Information
- German Research Foundation (PO 1575/3-1)
- Else-Kröner-Fresenius-Stiftung foundation (2012_A61, 2015_A06)
- German Cancer Aid (111620)
- European Hematology Association
- DKMS Foundation
- EMBO Young Investigator Programme
This publication has 28 references indexed in Scilit:
- Targeting RIG-I or STING promotes epithelial regenerationOncotarget, 2017
- Acute Graft-versus-Host Disease — Biologic Process, Prevention, and TherapyNew England Journal of Medicine, 2017
- RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injuryScience Translational Medicine, 2017
- Microbiota: a key orchestrator of cancer therapyNature Reviews Cancer, 2017
- Pathogenesis of acute graft‐versus‐host disease: from intestinal microbiota alterations to donor T cell activationBritish Journal of Haematology, 2016
- Thymus: the next (re)generationImmunological Reviews, 2016
- Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regenerationNature, 2015
- Complications of Allogeneic Hematopoietic Stem Cell TransplantationCancer Investigation, 2014
- Interleukin-22 Protects Intestinal Stem Cells from Immune-Mediated Tissue Damage and Regulates Sensitivity to Graft versus Host DiseaseImmunity, 2012
- Interleukin-22 Drives Endogenous Thymic Regeneration in MiceScience, 2012